top of page
FEBRUARY
NEPHRILYSIN
SEMAGLUTIDE
FLP IN CLD
RESMETIROM
JULY
​
NOVEMBER
END IN AIS
INEBILIZUMAB
MULTIPLE MYELOMA
SIRI & CAG
DECEMBER
LENACAPAVIR HIV
ATRASENTAN
CONICIZUMAB
XALANSIREN
​
​
bottom of page